featured image

Can Keto Help Depression, Anxiety, Bipolar Disorder, or ADHD?

A condition-by-condition look at ketogenic diets for mental health, from established epilepsy treatment to preliminary psychiatric research and safety concerns.

5 min read

The ketogenic diet has moved from epilepsy clinics into conversations about depression, anxiety, bipolar disorder, schizophrenia, and ADHD. The biological ideas are plausible. The clinical evidence is not equally strong across those conditions.

That difference is the heart of this article. “Keto changes brain metabolism” is not the same claim as “keto treats mental illness.”

What the Evidence SupportsEarly signalsProven for manyDiet quality may helpMonitor side effectsOngoing treatmentDo not self-taperEstablished CareExperimental Keto

First, What Is a Ketogenic Diet?

A ketogenic diet restricts carbohydrate enough to raise circulating ketone bodies, usually while supplying most energy from fat. It is more restrictive than simply eating fewer refined carbohydrates.

In medicine, ketogenic therapy is not just a list of foods. It may involve dietitian support, monitoring, supplements, medication changes, and specific targets based on the condition. The clearest established application is drug-resistant epilepsy, where randomized evidence shows that ketogenic therapies reduce seizures for some patients.1

Success in epilepsy gives researchers a reason to investigate psychiatry. It does not guarantee the same result for a different disorder.

Why Researchers Are Interested

Proposed mechanisms include changes in neuronal excitability, signaling molecules, inflammation, oxidative stress, the gut microbiome, and mitochondrial energy metabolism. Ketone bodies also act as signaling molecules rather than merely replacing glucose.

These mechanisms are hypotheses connecting a dietary intervention to possible effects. A mechanism can be real while the intervention proves ineffective, too small to matter, or too burdensome in clinical practice.

RESTRICTIVE DIET SUPPORTED CARE

Bipolar Disorder and Schizophrenia

This is currently the most active area of “metabolic psychiatry.” Case reports and small observational studies describe symptom improvement in some people. A 2024 pilot trial enrolled adults with schizophrenia or bipolar disorder who also had metabolic abnormalities. Participants showed improvements in several metabolic measures and psychiatric outcomes after a four-month ketogenic intervention.2

The findings are encouraging and justify larger trials. They do not establish remission rates for the general population because the study was small, had no randomized control group, and combined intensive support with the diet.

Keto should therefore be described as experimental adjunctive therapy, not a better replacement for antipsychotics or mood stabilizers.

Depression

Dietary improvement more broadly has modest randomized evidence for reducing depressive symptoms. Most of that evidence concerns Mediterranean-style or other high-quality dietary patterns—not ketogenic diets.3

For keto specifically, evidence for major depression consists largely of case reports, small studies, and indirect findings. There is not yet enough randomized evidence to conclude that ketosis treats depression or to specify a therapeutic ketone level.

Rapid early weight loss or a temporary sense of energy can also be mistaken for treatment of the underlying illness. Mood needs to be assessed over time and independently of the scale.

Anxiety

Animal studies and mechanistic arguments suggest possible effects, but direct clinical evidence for anxiety disorders is sparse. Anxiety can also worsen during dietary restriction, electrolyte shifts, sleep disruption, or obsessive monitoring.

It is not accurate to promise that ketosis will create “calm in the chaos.” A person whose anxiety improves while eating differently has had a valid experience, but that experience cannot establish average treatment effectiveness.

ADHD

ADHD is associated with eating patterns, obesity risk, sleep problems, and other health factors at a population level. None of those associations demonstrates that carbohydrate causes ADHD.

Direct human evidence that a ketogenic diet treats core ADHD symptoms is insufficient. Restrictive elimination diets are a separate research topic and should not be conflated with ketosis. Established ADHD care—including behavioral support, accommodations, sleep assessment, and medication when appropriate—has a much stronger evidence base.

PROPOSED MECHANISMS UNDER STUDY Brain Energy Neural Signaling Cellular Stress Metabolic Adaptation

Weight Loss, Regain, and Cardiovascular Risk

Keto often produces rapid initial weight loss. Glycogen depletion releases stored water, food choices narrow, and protein may improve satiety. The diet can also be hard to maintain. As adherence fades, its calorie deficit and early advantage fade too, and weight regain is common after any restrictive diet.4

The other concern is lipid response. Ketogenic diets rich in butter, coconut oil, cheese, and fatty meat can raise LDL cholesterol and ApoB. LDL-containing particles causally contribute to atherosclerotic cardiovascular disease, so a large increase should not be dismissed because triglycerides or glucose improved.5

If someone chooses keto, unsaturated fats—olive and canola oils, nuts, seeds, avocado, and fish—are preferable to building the diet around saturated fat. Lipids should be monitored, and a less restrictive pattern is reasonable when LDL/ApoB rises or adherence becomes a constant struggle.

SMALL PILOT STUDY IN SELECTED PATIENTS NEEDS RANDOMIZED REPLICATION

Who Needs Extra Caution?

Ketogenic diets can change hydration, blood pressure, and glucose quickly. Medical supervision is especially important for people who:

  • take insulin, sulfonylureas, SGLT2 inhibitors, lithium, blood-pressure medicine, or diuretics;
  • have type 1 diabetes, kidney, liver, pancreatic, or gallbladder disease;
  • are pregnant or breastfeeding;
  • have an active or previous eating disorder; or
  • are considering medication changes.

Stopping psychiatric medicine abruptly can trigger withdrawal, mania, psychosis, or relapse. Dietary change is not a safe reason to taper without the prescriber.

1. Evidence 2. Safety 3. Adherence

The Honest Bottom Line

Keto is established for drug-resistant epilepsy. For bipolar disorder and schizophrenia, early evidence is promising but preliminary. For depression, anxiety, and ADHD, the evidence is currently too limited to claim effectiveness.

A sustainable dietary pattern that supports cardiovascular and metabolic health may be more useful for most people than pursuing ketosis itself.

Footnotes

  1. Martin-McGill KJ, et al. “Ketogenic diets for drug-resistant epilepsy.” Cochrane Database of Systematic Reviews. 2020;(6):CD001903. ↩

  2. Sethi S, et al. “Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.” Psychiatry Research. 2024;335:115866. ↩

  3. Firth J, et al. “The Effects of Dietary Improvement on Symptoms of Depression and Anxiety.” Psychosomatic Medicine. 2019;81(3):265–280. ↩

  4. Gardner CD, et al. “Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults.” JAMA. 2018;319(7):667–679. ↩

  5. Ference BA, et al. “Low-density lipoproteins cause atherosclerotic cardiovascular disease.” European Heart Journal. 2017;38(32):2459–2472. ↩

How did this land?

Continue the conversation

What do you think?

Responses are reviewed before appearing publicly. Your email is never displayed.

We respect your privacy.

Reader conversation

Responses

Continue exploring

Where to explore next.